Can Triliaciclib Improve Chemotherapy Tolerance in Triple-Negative Breast Cancer?

The combination of trilaciclib and chemotherapy was generally well –tolerated with promising activity in a phase II trial of patients with metastatic triple-negative breast cancer.

Source: CancerNetwork - October 21, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news